Balakumar Chandrasekaran

Cited by

	All	Since 2019
Citations	1967	1699
h-index	26	25
i10-index	43	42

460

230

115

345

201120122013201420152016201720182019202020212022202320246 17 20 35 31 32 51 70 207 180 294 446 414 154

Public access

View all

19 articles

11 articles

available

not available

Based on funding mandates

Co-authors

Pran Kishore DebDepartment of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, RanchiVerified email at bitmesra.ac.in
Prof Rajshekhar KarpoormathUniversity of KwaZulu-NatalVerified email at ukzn.ac.za
Dr Rajwinder KaurProfessor, Chitkara College of Pharmacy, Chitkara University PunjabVerified email at chitkara.edu.in
Kaki Venkata RaoAssistant Professor, NIPER, HyderabadVerified email at niperhyd.ac.in
Dr. Krishnan Anand, MRSC.,Department of Chemical Pathology, University of the Free State, Bloemfontein, South AfricaVerified email at ufs.ac.za
Dr. Saravanan MuthupandianProfessor, Saveetha Institute of Medical and Technical Sciences (SIMATS)Verified email at saveetha.com
Girish HampannavarK.L.E. University's College of Pharmacy Vidyanagar, Hubballi - 580031Verified email at klecoph.edu.in
Mohammad F BayanAssociate Professor, Head of Pharmacy Department, Philadelphia UniversityVerified email at philadelphia.edu.jo
Dr. P. BoomiAssistant Professor, Alagappa UniversityVerified email at alagappauniversity.ac.in
Mailavaram Raghu PrasadProfessor of Pharmaceutical Chemistry, Shri Vishnu College of Pharmacy, Andhra UniversityVerified email at svcp.edu.in
Raghuram Rao AkkinepallyProfessor, University College of Pharmaceutical Sciences, Kakatiya UniversityVerified email at kakatiya.ac.in
Dr. Rakesh K. Tekade (Associate Prof...NIPER-A, IIT-Jammu, UTSouthwestern Texas (USA); University of Hawaii (USA), UCLan (UK), IMU-MalaysiaVerified email at niperahm.ac.in
Gurumallesh Prabu HalliahAlagappa UniversityVerified email at alagappauniversity.ac.in
Nikhil Agrawal,Ph.D.Honorary Research Fellow, UKZNVerified email at ukzn.ac.za
Sara Nidal AbedLoughborough UniversityVerified email at student.lboro.ac.uk
A M Y JaberPhiladelphia University JordanVerified email at philadelphia.edu.jo
Nizar Al-Shar'iProfessor of Medicinal Chemistry and Computer-Aided Drug DesignVerified email at just.edu.jo
Anil ChuturgoonDoctor of Philisophy, Medical Biochemistry, University of KwaZulu-Natal, Durban, South AfricaVerified email at ukzn.ac.za
Dr.S. JegatheeswaranDirector, BioMe Live Research Analytical Centre, Karaikudi, Tamilnadu, IndiaVerified email at zstu.edu.cn
D. JaradatAssociate Prof. of Chemistry, Department of Chemistry, Al-Balqa Applied UniversityVerified email at bau.edu.jo

Balakumar Chandrasekaran

Professor-Faculty of Pharmacy, Philadelphia University, Amman, Jordan

Verified email at philadelphia.edu.jo

Pharmaceutical Chemistry Medicinal Chemistry Drug Design Nanoparticles Pharmacology


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Synthesis, antiinflammatory evaluation and docking studies of some new fluorinated fused quinazolines C Balakumar, P Lamba, DP Kishore, BL Narayana, KV Rao, K Rajwinder, ... Eur. J. Med. Chem. 45 (11), 4904-4913, 2010	204	2010
An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold C Srinivasulu, K Rajshekhar, C Balakumar, GA Hampannavar, T Neeta, ... European Journal of Medicinal Chemistry 126, 298-352, 2017	162*	2017
Computer-aided prediction of pharmacokinetic (ADMET) properties B Chandrasekaran, SN Abed, O Al-Attraqchi, K Kuche, RK Tekade Dosage form design parameters, 731-755, 2018	160	2018
Phyto-Engineered Gold Nanoparticles (AuNPs) with Potential Antibacterial, Antioxidant, and Wound Healing Activities Under in vitro and in vivo Conditions B Pandi, G Ramalingam, GP Poorani, J Sonamuthu, B Chandrasekaran, ... International Journal of Nanomedicine, 2020	101	2020
Protein/peptide drug delivery systems: practical considerations in pharmaceutical product development PK Deb, O Al-Attraqchi, B Chandrasekaran, A Paradkar, RK Tekade Basic Fundamentals of Drug Delivery, 651-684, 2019	58	2019
Synthesis, anticancer evaluation, and molecular docking studies of some novel 4, 6-disubstituted pyrazolo [3, 4-d] pyrimidines as cyclin-dependent kinase 2 (CDK2) inhibitors S Cherukupalli, B Chandrasekaran, V Kryštof, RR Aleti, N Sayyad, ... Bioorganic chemistry 79, 46-59, 2018	57	2018
Synthesis, Anti-inflammatory evaluation and docking studies of some new thiazole derivatives. PK Deb, K Rajwinder, C Balakumar, B Madhu, G Dilshad, K Venkat Rao, ... Med Chem Res. 23, 2780-2792, 2014	54	2014
Neurological consequences of SARS-CoV-2 infection and concurrence of treatment-induced neuropsychiatric adverse events in COVID-19 patients: navigating the uncharted P Borah, PK Deb, B Chandrasekaran, M Goyal, M Bansal, S Hussain, ... Frontiers in molecular biosciences 8, 627723, 2021	53	2021
Green biosynthesis of gold nanoparticles using Croton sparsiflorus leaves extract and evaluation of UV protection, antibacterial and anticancer applications P Boomi, GP Poorani, S Selvam, S Palanisamy, S Jegatheeswaran, ... Applied Organometallic Chemistry 34 (5), e5574, 2020	52	2020
Dehydrozingerone inspired styryl hydrazine thiazole hybrids as promising class of antimycobacterial agents GA Hampannavar, K Rajshekhar, MB Palkar, MS Shaikh, C Balakumar ACS Med. Chem. Lett. 7, 686-691, 2016	51	2016
QSAR of adenosine receptor antagonists: Exploring physicochemical requirements for binding of pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives with human adenosine A3 … DP Kishore, C Balakumar, AR Rao, PR Partha, K Roy Bioorganic Medicinal Chemistry Letters 21 (2), 818-823, 2011	48	2011
Synthesis of 4, 6-disubstituted pyrazolo [3, 4-d] pyrimidine analogues: Cyclin-dependent kinase 2 (CDK2) inhibition, molecular docking and anticancer evaluation S Cherukupalli, B Chandrasekaran, RR Aleti, N Sayyad, ... Journal of Molecular Structure 1176, 538-551, 2019	46	2019
Molecular modeling evaluation of non-steroidal aromatase inhibitors LN Bheemanapalli, PK Deb, B Chadrasekaran, VR Kaki, K Rajwinder, ... Chemical Biology and Drug Design 79 (5), 674-682, 2012	43*	2012
An appraisal on synthetic and pharmaceutical perspectives of pyrazolo [4, 3-d] pyrimidine scaffold S Cherukupalli, GA Hampannavar, S Chinnam, B Chandrasekaran, ... Bioorganic & Medicinal Chemistry 26 (2), 309-339, 2018	41	2018
Perspectives on RNA vaccine candidates for COVID-19 P Borah, PK Deb, NA Al-Shar’i, LA Dahabiyeh, KN Venugopala, V Singh, ... Frontiers in Molecular Biosciences 8, 635245, 2021	40	2021
Emerging therapeutic approaches to combat COVID-19: present status and future perspectives K Vivekanandhan, P Shanmugam, H Barabadi, V Arumugam, ... Frontiers in Molecular Biosciences 8, 604447, 2021	39	2021
Prospective role of peptide-based antiviral therapy against the main protease of SARS-CoV-2 S Mahmud, GK Paul, S Biswas, S Afrose, MA Mita, MR Hasan, ... Frontiers in Molecular Biosciences 8, 628585, 2021	38	2021
Synthesis, adenosine receptor binding and molecular modelling studies of novel thieno[2,3‐d]pyrimidine derivatives PK Deb, R Mailavaram, B Chandrasekaran, VR Kaki, R Kaur, S Kachler, ... Chemical biology & drug design 91 (4), 962-969, 2018	37	2018
Molecular modeling approaches for the discovery of adenosine A2B receptor antagonists: current status and future perspectives PK Deb, B Chandrasekaran, R Mailavaram, RK Tekade, AMY Jaber Drug discovery today 24 (9), 1854-1864, 2019	32	2019
Developmental landscape of potential vaccine candidates based on viral vector for prophylaxis of COVID-19 R Bezbaruah, P Borah, BB Kakoti, NA Al-Shar’I, B Chandrasekaran, ... Frontiers in Molecular Biosciences 8, 635337, 2021	31	2021

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors